Maryanne Demasi, reports

Share this post
Response to a critique of our statin analysis
maryannedemasi.substack.com

Response to a critique of our statin analysis

Maryanne Demasi, PhD
Jan 25
498
328
Share this post
Response to a critique of our statin analysis
maryannedemasi.substack.com

By Maryanne Demasi, PhD, Paula Byrne, PhD, Mark Jones, PhD, Robert DuBroff, MD. On several occasions, we have been asked to respond to a critique of our 2022 systematic review and meta-analysis on statin trials. The critique was written by Peter Attia in April 2022, a physician and popular podcaster whose interests lie at the intersection of longevity, lipids and heart disease.

Read →
  • New First
  • Chronological
© 2023 Maryanne Demasi
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing